PLx Pharma Lands $8,273,297 New Funding Round

  • Feed Type
  • Date
    3/20/2013
  • Company Name
    PLx Pharma
  • Mailing Address
    8285 El Rio Houston, TX 77054
  • Company Description
    PLx Pharma is a pharmaceutical company developing the next generation of non-steroidal anti-inflammatory agents (NSAIDs) that are safer on the gut.
  • Website
    http://www.plxpharma.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $8,273,297
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy